Close Menu

NEW YORK (GenomeWeb) – Ambry Genetics announced this week that it has opened its AmbryShare data sharing program to the public. AmbryShare contains data on more than 1 million variants from 11,400 hereditary breast and ovarian cancer patients. It is comprised of de-identified aggregated allele frequency data that includes analysis of all genes in the human genome. The company is also soliciting collaborations with interested researchers for new AmbryShare exome projects on autism and prostate cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.